Drugmakers rally after Pfizer agreement as Most Favored Nation plans still loom over sector.

Pfizer's deal with Trump was a relief to the pharma industry, signaling that drugmakers could strike similar agreements that would make them immune to tariffs.

Drugmakers rally after Pfizer agreement as Most Favored Nation plans still loom over sector.